Literature DB >> 30373411

Comparison of Surgically Excised Premacular Membranes in Eyes with Macular Pucker and Proliferative Vitreoretinopathy.

Stefanie R Guenther1, Ricarda G Schumann1, Felix Hagenau1, Armin Wolf1, Siegfried G Priglinger1, Denise Vogt1.   

Abstract

PURPOSE: To describe and compare characteristics of premacular membranes in idiopathic macular pucker (iMP) and proliferative vitreoretinopathy (PVR) using immunofluorescence and transmission electron microscopy.
MATERIALS AND METHODS: For immunocytochemical and ultrastructural analyses, premacular membranes were harvested during vitrectomy from 16 eyes with iMP and 12 eyes with PVR. All specimens were processed as flat mounts for phase-contrast and fluorescence microscopy. We used 19 different primary antibodies such as anti-α-smooth muscle actin (α-SMA), anti-integrin-αv, anti-galectin, anti-IBA-1, anti-EMMPRIN (CD147), anti-ricinus (RCS) and anti-collagen-type I. Eight of 28 eyes were also prepared for transmission electron microscopy.
RESULTS: In all eyes with iMP and PVR, positive immunoreactivity of integrins, especially αvβ3 was found. There was also a strong staining of anti-α-SMA, anti-galectin, anti-EMMPRIN, anti-RCS, anti-IBA1 and anti-collagen-type I. Transmission electron microscopy showed that premacular membrane of iMP composed of myofibroblasts, glial cells and fibroblasts. In eyes with PVR, retinal pigment epithelial cells and myofibroblasts were seen as predominant cell types.
CONCLUSION: Premacular membranes of iMP and PVR presented with similarities in cell distribution and immunoreactivity, but showed differences in cell composition. Herein, we demonstrate immunocytochemical characteristics involved in fibrotic processes. Cell transdifferentiation into myofibroblasts represents an important process in pathogenesis of both entities. In order to address future anti-fibrotic treatment strategies, we emphasize that both fibrotic diseases share distinct immunocytochemical and ultrastructural features.

Entities:  

Keywords:  Epiretinal membrane; immunocytochemistry; macular pucker; proliferative vitreoretinopathy; transmission electron microscopy

Mesh:

Substances:

Year:  2019        PMID: 30373411     DOI: 10.1080/02713683.2018.1542006

Source DB:  PubMed          Journal:  Curr Eye Res        ISSN: 0271-3683            Impact factor:   2.424


  8 in total

Review 1.  [Statement of the Professional Association of German Ophthalmologists (BVA), the German Ophthalmological Society (DOG) and the Retinological Society (RG) on the development, diagnostics and treatment of epiretinal gliosis : Status October 2020].

Authors: 
Journal:  Ophthalmologe       Date:  2021-02       Impact factor: 1.059

Review 2.  [Proliferative vitreoretinopathy (PVR) minimal: same, same but different. Characteristics and surgical treatment of PVR-associated macular pucker].

Authors:  L-O Hattenbach; S Grisanti; S G Priglinger; A Chronopoulos
Journal:  Ophthalmologe       Date:  2021-01       Impact factor: 1.059

Review 3.  Inflammatory mediators of proliferative vitreoretinopathy: hypothesis and review.

Authors:  Ying Dai; Chenghua Dai; Tao Sun
Journal:  Int Ophthalmol       Date:  2020-02-26       Impact factor: 2.031

4.  Topical delivery of a small molecule RUNX1 transcription factor inhibitor for the treatment of proliferative vitreoretinopathy.

Authors:  Santiago Delgado-Tirado; Dhanesh Amarnani; Guannan Zhao; Elizabeth J Rossin; Dean Eliott; John B Miller; Whitney A Greene; Leslie Ramos; Said Arevalo-Alquichire; David Leyton-Cifuentes; Lucia Gonzalez-Buendia; Daniela Isaacs-Bernal; Hannah A B Whitmore; Natalia Chmielewska; Brandon V Duffy; Eric Kim; Heuy-Ching Wang; Jose M Ruiz-Moreno; Leo A Kim; Joseph F Arboleda-Velasquez
Journal:  Sci Rep       Date:  2020-11-30       Impact factor: 4.379

5.  Yes-associated protein is essential for proliferative vitreoretinopathy development via the epithelial-mesenchymal transition in retinal pigment epithelial fibrosis.

Authors:  Wei Zhang; Jing Li
Journal:  J Cell Mol Med       Date:  2021-10-01       Impact factor: 5.310

6.  MicroRNA-4516 suppresses proliferative vitreoretinopathy development via negatively regulating OTX1.

Authors:  Shu-I Pao; Le-Tien Lin; Yi-Hao Chen; Ching-Long Chen; Jiann-Torng Chen
Journal:  PLoS One       Date:  2022-06-30       Impact factor: 3.752

Review 7.  Untangling the Extracellular Matrix of Idiopathic Epiretinal Membrane: A Path Winding among Structure, Interactomics and Translational Medicine.

Authors:  Laura Bianchi; Annalisa Altera; Virginia Barone; Denise Bonente; Tommaso Bacci; Elena De Benedetto; Luca Bini; Gian Marco Tosi; Federico Galvagni; Eugenio Bertelli
Journal:  Cells       Date:  2022-08-15       Impact factor: 7.666

8.  Postoperative Macular Proliferative Vitreoretinopathy: A Case Series and Literature Review.

Authors:  Samer Khateb; Hamzah Aweidah; Michael Halpert; Tareq Jaouni
Journal:  Case Rep Ophthalmol       Date:  2021-05-27
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.